<DOC>
	<DOCNO>NCT01997164</DOCNO>
	<brief_summary>The primary objective study investigate safety tolerability intravitreal ( IVT ) REGN910-3 IVT REGN910 patient neovascular age-related macular degeneration ( AMD ) , separately patient diabetic macular edema ( DME ) .</brief_summary>
	<brief_title>Study Intravitreal ( IVT ) REGN910-3 IVT REGN910 Patients With Either Neovascular ( `` Wet '' ) Age Related Macular Degeneration ( AMD ) Diabetic Macular Edema ( DME )</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Wet Macular Degeneration</mesh_term>
	<criteria>Key 1 . For patient AMD : 1 . Active subfoveal choroidal neovascularization ( CNV ) secondary AMD , include juxtafoveal lesion affect fovea evidence FA OCT study eye , determine investigator 2 . Men woman ≥50 year old 2 . For patient DME : 1 . Patients clinically significant DME central involvement ( ≥300 μm central subfield spectral domain OCT ) 2 . Men woman ≥18 year old Key 1 . For patient neovascular AMD : 1 . Evidence choroidal neovascularization ( CNV ) due cause AMD either eye 2 . Evidence diabetic retinopathy ( DR ) DME either eye 2 . For patient DME : Evidence neovascular AMD CNV due cause either eye 3 . Prior IAI either eye 4 . IVT bevacizumab , ranibizumab , pegaptanib sodium study eye within 8 week day 1 AE previous treatment would preclude administration drug study 5 . Any prior treatment angiopoietin inhibitor 6 . Any prior systemic ( IV ) antiVEGF administration 7 . History vitreoretinal surgery study eye 8 . Pan retinal laser photocoagulation macular laser photocoagulation study eye within 3 month screen visit 9 . Previous use intraocular periocular corticosteroid study eye within 4 month screen ( The inclusion/ exclusion criterion provide intend contain consideration relevant subject 's potential participation clinical trial ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>